Marker Therapeutics, Inc. (MRKR)

2.04 -0.15 (-6.85%) USD  |  NASDAQ  |  Jan 22, 16:00
2.07 +0.03 (+1.47%) After-Hours: 07:55
More

Marker Therapeutics Monthly Value at Risk (VaR) 5% (3Y Lookback)

Monthly Value at Risk (VaR) 5% (3Y Lookback) Chart

View Monthly Value at Risk (VaR) 5% (3Y Lookback) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Monthly Value at Risk (VaR) 5% (3Y Lookback) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Value At Risk (VaR) Definition

View Value At Risk (VaR) Definition
Start Trial

The VaR calculates the potential loss of an investment with a given time frame and confidence level.

Read full definition.

Monthly Value at Risk (VaR) 5% (3Y Lookback) Range, Past 5 Years

View Monthly Value at Risk (VaR) 5% (3Y Lookback) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Monthly Value at Risk (VaR) 5% (3Y Lookback) Benchmarks

View Monthly Value at Risk (VaR) 5% (3Y Lookback) Benchmarks
Start Trial
Viridian Therapeutics, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Kiniksa Pharmaceuticals International Plc Upgrade
Neurocrine Biosciences, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade

Monthly Value at Risk (VaR) 5% (3Y Lookback) Related Metrics

Alpha (3Y) Upgrade
Beta (3Y) Upgrade
Annualized Standard Deviation of Monthly Returns (3Y Lookback) Upgrade
Historical Sharpe Ratio (3Y) Upgrade
Historical Sortino (3Y) Upgrade
Max Drawdown (3Y) Upgrade